Whitehawk Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-86.2M | $1.6M |
| FY2017 | — | $17.4M | $20.3M |
| FY2018 | — | $58.7M | $62.6M |
| FY2019 | — | $-9.1M | $38.5M |
| FY2020 | — | $-12.4M | $4.5M |
| FY2021 | — | $136.4M | $149.0M |
| FY2022 | — | $158.4M | $39.0M |
| FY2023 | — | $105.2M | $62.9M |
| FY2024 | — | $52.5M | $28.7M |
| FY2025 | — | $136.3M | $37.6M |